Ascent Industries Co. (NASDAQ:ACNT – Get Free Report) VP Anthony X. Pan purchased 2,000 shares of the stock in a transaction dated Friday, September 20th. The stock was bought at an average cost of $9.42 per share, with a total value of $18,840.00. Following the completion of the purchase, the vice president now owns 10,570 shares in the company, valued at $99,569.40. The purchase was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Ascent Industries Trading Up 0.2 %
Shares of ACNT stock traded up $0.02 on Tuesday, reaching $9.66. The company had a trading volume of 51,897 shares, compared to its average volume of 19,378. The company has a current ratio of 3.16, a quick ratio of 1.45 and a debt-to-equity ratio of 0.01. The stock has a market cap of $97.86 million, a PE ratio of -3.74 and a beta of 0.79. The company has a 50-day moving average of $9.91 and a 200-day moving average of $10.09. Ascent Industries Co. has a 12 month low of $7.20 and a 12 month high of $11.19.
Ascent Industries (NASDAQ:ACNT – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported ($0.02) EPS for the quarter. The company had revenue of $50.19 million during the quarter. Ascent Industries had a negative net margin of 6.89% and a negative return on equity of 12.99%.
Institutional Trading of Ascent Industries
Ascent Industries Company Profile
Ascent Industries Co an industrials company, produces and distributes stainless steel pipe and tube and specialty chemicals in the United States and internationally. The company operates through two segments, Tubular Products and Specialty Chemicals. It manufactures welded pipes and tubes, primarily from stainless steel, duplex, and nickel alloys; and ornamental stainless steel tubes for automotive, commercial transportation, marine, food services, construction, furniture, healthcare, and other industries.
Read More
- Five stocks we like better than Ascent Industries
- What is an Earnings Surprise?
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- Election Stocks: How Elections Affect the Stock Market
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- What Investors Need to Know About Upcoming IPOs
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Ascent Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascent Industries and related companies with MarketBeat.com's FREE daily email newsletter.